13F Insight
DOSSIER · 13F Holders · Q2 2026

NEUROSENSE THERAPEUTICS LTD

12 institutions still hold NEUROSENSE THERAPEUTICS LTD as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP M74240108·12 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$285K
visible holders
Holders
12
filers reporting
Concentration
27.43%
UBS Group AG #1
top holder share
AI Holders Summary · Q2 2026

12 institutions reported NEUROSENSE THERAPEUTICS LTD in Q2 2026. UBS Group AG leads at 27.4% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
UBS Group AG
CIK 0001610520
$78K109K0.00%Q2 202602
Independent Advisor Alliance
CIK 0001696899
$72K100K0.00%Q2 202603
Yorkville Advisors Global, LP
CIK 0001838613
$56K78K0.07%Q2 202604
JANE STREET GROUP, LLC
CIK 0001595888· Market maker
$22K29K0.00%Q1 202605
COMMONWEALTH EQUITY SERVICES, LLC
CIK 0000312272
$16K23K0.00%Q2 202606
Pathstone Holdings, LLC
CIK 0002011612
$12K17K0.00%Q2 202607
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$11K16K0.00%Q2 202608
XTX Topco Ltd
CIK 0001828301
$8K11K0.00%Q2 202609
Creative Planning
CIK 0001540235
$8K11K0.00%Q2 202610
JONES FINANCIAL COMPANIES LLLP
CIK 0000815917
$7571K0.00%Q2 202611
SBI Securities Co., Ltd.
CIK 0001851815
$1842550.00%Q2 202612
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025